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Background. End-stage renal disease represents a serious
public health problem in Jalisco, Mexico. It is reported among
the 10 leading causes of death, with an annual mortality rate of
12 deaths per 100,000 population. The state population is 6.3
million, and more than half do not have medical insurance. In
this study, we report the population’s access to renal replace-
ment therapy (RRT).
Methods. Patients ≥15 years of age, who started RRT be-
tween January 1998 and December 2000 at social security or
health secretariat medical facilities, were included. Nine facil-
ities participated in the study. At the start of treatment, the
patient’s facility, age, gender, cause of renal failure, and initial
treatment modality were registered.
Results. Within the study period, 2456 started RRT, 1767
(72%) at social security facilities and 687 (28%) at health sec-
retariat facilities, for an annual incidence rate of 195 per million
population (pmp). The main cause of renal failure was diabetes
mellitus (51% of patients). There were significant differences
between the 2 populations. Patients with social security were
older (53.1 ± 17 vs. 45.1 ± 20 years, P = 0.001) and had more di-
abetes (54% vs. 42%, P = 0.001) than those without social secu-
rity. They had higher acceptance (327 pmp vs. 99 pmp, P = 0.001)
and prevalence rates (939 pmp vs. 166 pmp, P = 0.001) than pa-
tients without medical insurance. Dialysis use was similar in
both populations. Eighty-five percent of patients were on con-
tinuous ambulatory peritoneal dialysis and 15% on hemodial-
ysis. Kidney transplant rate was higher among insured patients
(72 pmp vs. 7.5 pmp, P = 0.001). The number of dialysis pro-
grams and nephrologists that offered renal care also differed.
There were 10 dialysis programs in social security and 3 in health
secretariat facilities. Fourteen nephrologists looked after the in-
sured population, whereas 5 cared for the uninsured (7.7 pmp
vs. 2.1 pmp, P = 0.001). The latter had access to 8 hemodialysis
stations compared with 34 for the insured population (3.4 pmp
vs. 18.8 pmp, P = 0.001).
Conclusions. Access to RRT is unequal in our state. Although
it is universal for the insured population, it is severely restricted
for the poor. Social and economical factors, as well as the lim-
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ited number of understaffed, centralized dialysis facilities, could
explain these differences.
Resumen
Antecedentes. La insuficiencia renal cro´nica representa un
serio problema de salud pu´blica en el estado de Jalisco. Se en-
cuentra entre las 10 causas ma´s frecuentes de muerte con una
tasa de 12 fallecimientos por 100,000 habitantes. Nuestro es-
tado cuenta con una poblacio´n de 6.3 millones de habitantes y
ma´s de la mitad de ellos no cuentan con seguridad social. En
el presente estudio reportamos el acceso de ellos a terapias de
reemplazo renal (TRR).
Me´todos. Se incluyeron pacientes ≥ 15 an˜os de edad que
iniciaron TRR entre Enero de 1998 y Diciembre de 2000 en
instituciones de la seguridad social y de la Secretarı´a de Salud.
Nueve instituciones participaron en el estudio. A su ingreso se
registraron la institucio´n, edad, ge´nero, causa de la falla renal y
el tipo de terapia inicial.
Resultados. En el periodo de estudio, 2,456 iniciaron TRR,
1,767 (72%) en la seguridad social y 687 (28%) en la institu-
ciones de la Secretarı´a de Salud, para una incidencia anual de
195 por millo´n de habitantes (pmh). La principal causa de falla
renal fue la diabetes mellitus (51% de los casos). Se observaron
diferencias importantes entre las dos poblaciones. Los pacientes
con seguridad social tenı´an ma´s edad (53.1 ± 17 vs 45.1 ± 20
an˜os, P = 0.001) y ma´s diabetes (54% vs 42%), P = 0.001)
que los no asegurados. Su acceso a dia´lisis (327 vs 99 pmh,
P = 0.001) y su prevalencia (939 vs 166 pmh, P = 0.001) fue
mayor que los pacientes sin seguro me´dico. La utilizacio´n de
dia´lisis fue similar en los dos grupos; 85% se encontraban en
dia´lisis peritoneal continua ambulatoria y 15% en hemodia´lisis.
La tasa de trasplante fue mayor en pacientes con seguridad so-
cial que en los no asegurados (72 vs 7.5 trasplantes pmh, P =
0.001). En total, el nu´mero de programas de dia´lisis y el nu´mero
de nefro´logos para la atencio´n de los dos grupos, tambie´n fue
diferente. Mientras que los pacientes con seguridad social tenı´an
acceso a 10 programas, solo existı´an 3 para los no asegurados.
14 nefro´logos atendı´an a los asegurados, mientras que solo 5
atendı´an a los no asegurados (7.7 vs 2.1 pmh, P = 0.001). Estos
u´ltimos tenı´an acceso a 8 estaciones de dia´lisis, comparado con
34 para la poblacio´n asegurada (3.4 vs 18.8 pmh, P = 0.001).
Conclusiones. El acceso a las TRR en nuestro estado no es eq-
uitativo. Mientras que es universal para la poblacio´n asegurada,
se encuentra muy limitado para la no asegurada. Factores so-
ciales y econo´micos, ası´ como el nu´mero limitado de programas
de dia´lisis y de nefro´logos, pudieran explicar estas diferencias.
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BACKGROUND
In the last 60 years, Mexico has experienced major eco-
nomic changes that have resulted in a significant improve-
ment in the health of its inhabitants. It is in this context
that the country’s epidemiologic and demographic tran-
sitions have occurred. In 1940, life expectancy was 52
years, and communicable diseases represented 60% of
the country’s general mortality. Currently, life expectancy
has reached 76 years, and communicable diseases repre-
sent only 15% of the causes of death. Consequently, the
aging of the population began. In 1940, there were 2.8
million people aged 45 to 65 years; currently, there are
15 million, and it is expected that in the year 2020 this
group will reach 17 million [1, 2]. Also, along with the
industrialization of the country that started at the end
of World War II, a migration from rural to urban areas
began, changing the lifestyle of the population at large.
However, this success has been followed by the emer-
gence of chronic degenerative diseases such as diabetes
mellitus, cardiovascular, and chronic renal disease. Cur-
rently, noncommunicable diseases account for 57% of the
general mortality [2]. According to the National Health
Survey 2000, 8% of the population has diabetes and 31%
have arterial hypertension [3]. It is estimated that close to
30,000 patients are on dialysis, with an annual acceptance
rate of 124 per million population (pmp) [4].
The State of Jalisco is located in western Mexico. It has
6.3 million inhabitants, 66% of which are older than 15
years of age, and Jalisco is the country’s third largest econ-
omy. Fifty-five percent of the population lives in the state
capital, Guadalajara [5]. The health care system, as in the
rest of the country, is organized by segments. Those who
have a salary or who belong to the state’s bureaucracy
or armed forces have social security benefits, including
access to dialysis. However, they represent less than half
of the state population. Less than 2% hold private health
insurance. The remaining 54% do not have access to so-
cial security and cannot afford to pay for private medicine
[2] (Fig. 1). This segment of the population seeks medical
care at the facilities of the state’s health secretariat. The
aim of our study is to compare access to dialysis among
these 2 populations.
METHODS
The Jalisco State Dialysis and Transplant Registry
was organized in 1993 with the objective of keeping
an epidemiologic surveillance of end-stage renal disease
(ESRD) and its treatment in our state. Nine public and
one private institution have participated in the registry,
representing close to 90% of the dialysis and transplant
population. All patients ≥15 years of age, who started
renal replacement therapy (RRT) between January 1998
and December 2000 at social security or health secretariat
medical facilities, were included in this report. At the start
Private 1%
Social Security 45% Uninsured 54%
Fig. 1. Health Care in Jalisco. Distribution by type of medical insur-
ance.
Table 1. Characteristics of patients with incident 15 years of age and
older, according to type of health care facility. Adjusted by age
Social security Health secretariat
N = 1769 N = 687 P value
Age years 53.1 ± 17 45.1 ± 20 0.001
Gender% female 46.5 41.9 0.90
Diabetes% 54 42 0.001
Acceptance ratea 327 99 0.001
Prevalence ratea 939 166 0.001
Transplant ratea 72 9 0.001
aPer million population.
of dialysis, the patient’s institution, age, gender, etiology
of renal disease, and initial treatment modality were reg-
istered. Incidence and prevalence rates were adjusted by
age. All data were stored in computing files using EPI6
software (Version 6; Centers for Disease Control and Pre-
vention, Atlanta, GA, USA). Comparisons were made
using analysis of variance or chi-square when appropri-
ate. Statistical analysis was performed using SPSS (Ad-
vance Statistics, release 6.0; Statistical Package for the
Social Sciences; Chicago, IL, USA) and EPI6 software.
RESULTS
Between January 1998 and December 2000, 2456 pa-
tients started RRT—1767 (72%) at social security and
687 (28%) at health secretariat facilities—for an an-
nual incidence rate of 195 pmp. The main causes of re-
nal failure were diabetes mellitus (51%), undetermined
(31%), chronic glomerulonephritis (6%), hypertension
(4%), and miscellaneous (5%). There were significant
differences between insured and uninsured groups. Pa-
tients with medical insurance were older (53.1 ± 17 years
vs. 45.1 ± 20 years, P = 0.001) and had a greater incidence
of diabetes (54% vs. 42%, P = 0.001) than the uninsured
(Table 1). They had a higher acceptance rate (327 pmp vs.
99 pmp, P = 0.001) than patients without medical insur-
ance. A lower acceptance rate was seen in all age groups.
Also, in a larger number of uninsured patients the cause of
renal failure was unknown (35.9% vs. 23.4%, P = 0.001).
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Kidney transplant 18%
Hemodialysis 12%
CAPD 70%
Fig. 2. Distribution of prevalent patients by type of renal replacement
therapy.
Table 2. Number of dialysis programs and nephrologists offering
renal care in the state of Jalisco, Mexico from 1998–2000
Social security Health secretariat
Population m 1.8 2.3
Dyalisis programs n 10 3
Transplant programs n 1 1
HD stations pmp 18.8 3.4
Nephrologists pmp 7.7 2.1
Abbreviations are: pmp, per million population; HD, hemodialysis.
Adjusted by age. P = 0.001.
At the end of the year 2000, 2075 patients were on
dialysis or had a functioning kidney graft, for a preva-
lence rate of 494 patients pmp. The prevalence rate was
significantly higher among insured than uninsured popu-
lations (939 pmp vs. 166 pmp, P = 0.001). Diabetes melli-
tus represented 53% of all causes of renal failure among
patients on dialysis. Seventy percent of patients were on
continuous ambulatory peritoneal dialysis (CAPD), 12%
on hemodialysis, and 17% had a functioning graft (Fig. 2).
Dialysis use was similar in both populations. Eighty-five
percent of patients were on CAPD and 15% were on
hemodialysis.
The number of dialysis programs and nephrologists
that offer renal care also differed between these 2 popula-
tions (Table 2). There were 3 programs offering dialysis to
the uninsured and 10 programs to those with social secu-
rity. Fourteen nephrologists looked after the insured pop-
ulation, whereas 5 cared for the uninsured (7.7 pmp vs.
2.1 pmp, P = 0.001). The latter had access to 8 hemodial-
ysis stations compared with 34 stations for the insured
population (3.4 pmp vs. 18.8 pmp, P = 0.001).
Finally, although there was 1 transplant program for
each population, the transplant rate was also different,
at 72 pmp for those with social security and 7.5 pmp for
those without it (P = 0.001).
DISCUSSION
ESRD represents a serious public health problem in
our state. It is reported among the 10 leading causes of
death, with an annual mortality rate of 12 deaths per
100,000 population [2].
In the population ≥15 years of age, the annual inci-
dence was 195 patients pmp with a prevalence rate of 494
patients pmp. However, the fragmentation and central-
ization of the health care system in our state, like in the
rest of the country, have resulted in unequal access to
renal care [6, 7].
More than half of the state’s population does not have
social security. Their annual acceptance rate to dialysis
was only 99 pmp, well below the rate of 327 pmp re-
ported for the insured population. Because it is highly
unlikely that the frequency of renal failure was lower
among the uninsured, the difference observed could be
due to limited access to dialysis, explained in part by
the small number of understaffed dialysis facilities in the
health secretariat sector. Indeed, there were only 3 dialy-
sis facilities, 8 hemodialysis stations, and 5 nephrologists
providing care to 2.3 million of adults without medical
insurance.
Two additional factors could explain these differences.
Despite the fact that 45% of the state population live out-
side the state capital, all 3 dialysis facilities belonging to
the health secretariat are located in Guadalajara, which is
a far distance from this population. Furthermore, access
to dialysis is limited to those patients who can pay part of
their treatment expenses, afford to travel to the state cap-
ital, and meet the minimum living standards required by
CAPD, which limits access to these programs still further.
The result is that although they are 54% of the state pop-
ulation, they represent only 18% of the prevalent dialysis
and transplant population.
We observed a lower incidence of diabetic nephropa-
thy among the poor. It has been recently reported that
the prevalence of diabetes in Mexico is lower among the
uninsured (6.2%) compared with the group observed in
the population that has social security (10%) [3]. How-
ever, in a prospective study of patients referred to dialysis
in a large tertiary-care facility of the health secretariat,
54% of them had diabetes, similar to the incidence rate
seen among patients with social security [8]. Therefore,
it is possible that some form of rationing exists, and that
patients with diabetes without social security were less
likely to be accepted to dialysis.
Diabetes mellitus has become the main cause of ESRD
in our state, representing 51% of new patients with
ESRD. This is not surprising, because it is estimated that
8% of the state population have mostly type 2 diabetes
[3]. Because potentially 30% of these patients will even-
tually develop kidney disease, this will become a serious
public health issue in the near future.
As in the rest of Mexico, CAPD continues to be
the leading modality of treatment, representing 85% of
the dialysis population. The reason for this is not com-
pletely clear, although it has been argued that CAPD is
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cheaper and easier to implement than hemodialysis. In-
deed, Otero et al have estimated that the annual costs
of a patient in CAPD and in hemodialysis in our country
are US $5000 and US $12,000, respectively [9]. Neverthe-
less, hemodialysis has experienced a significant growth in
recent years. In 1995, only 5% of the state dialysis pop-
ulation was on hemodialysis; by 2000 they represented
15%. There were 25 hemodialysis stations in 1995 com-
pared with 89 in 2003. Unfortunately, this growth has been
largely observed at facilities belonging to the social secu-
rity sector. Although the number of stations increased
from 7 to 10 for the uninsured population, the number
has increased from 25 to 89 for patients with social se-
curity. However, the number of stations continues to be
insufficient in matching the growing demand. The ma-
jority of patients receive only two 3.5-hour sessions per
week, leaving this modality of treatment largely as a sec-
ond option for CAPD failures.
Finally, although Jalisco has experienced one of the
largest increases in kidney transplant rates in the country
since 1998, going from 18 to 59 transplants pmp [10, 12],
its medical success has not been shared by the poor, where
only 9 transplants pmp are performed annually.
CONCLUSION
ESRD has become a serious public health problem in
our state, representing a high cost for society not only
because of the costs of its treatment, but because of the
number of deaths due to kidney disease. The main cause
of ESRD is diabetes, and it is expected to increase in
the future. The current infrastructure and resources to
offer renal care are insufficient to satisfy the growing de-
mand for dialysis and kidney transplantation in our pop-
ulation. Likewise, access to RRT is unequal in our state.
Although access is almost universal for the insured pop-
ulation, it is severely restricted for the poor. Social, cul-
tural, and economic factors, as well as a limited number of
understaffed, centralized dialysis facilities could explain
these differences. Therefore, it is of paramount impor-
tance to consider renal disease a public health priority
and to implement a program of prevention and treat-
ment, following the guidelines included in the National
Health Program 2001–2006, developed by the Mexican
government [12]. The establishment of a national reg-
istry, the development of dialysis regulations, as well as
the training of more nephrology professionals, nurses and
physicians alike, will lead to a more efficient dialysis and
transplant program. The eventual extension of the Popu-
lar Insurance Program to cover catastrophic illness such
as ESRD will ease the limited access to RRT among the
poor in our country.
However, because it is highly unlikely that Mexico will
be able to afford the expense of maintaining a large dialy-
sis population as in the developed world, it is only through
prevention that we can face this devastating disease. It
has been shown that regular exercise, a low-calorie diet,
and the management of an ideal weight can prevent type
2 diabetes mellitus [13]. Also, early detection of renal
disease allows the use of strategies that retard its pro-
gression [14]. Prevention of renal disease should become
a national priority; otherwise there won’t be sufficient fi-
nancial or human resources to cope with this catastrophic
illness.
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